nach oben

Metabolic Brain Disease

Erschienen in:

01.09.2012 | Original Paper

1H-MRS in autism spectrum disorders: a systematic meta-analysis

verfasst von: Jonathan C. Ipser, Supriya Syal, Judy Bentley, Colleen M. Adnams, Bennie Steyn, Dan J. Stein

Erschienen in: Metabolic Brain Disease | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

We conducted a systematic review and meta-analysis of proton magnetic resonance spectroscopy (1H-MRS) studies comparing autism spectrum disorder (ASD) patients with healthy controls, with the aim of profiling ASD-associated changes in the metabolites N-acetyl-aspartate (NAA) and Creatine (Cr). Meta-regression models of NAA and Cr levels were employed, using data from 20 eligible studies (N = 852), to investigate age-dependent differences in both global brain and region-specific metabolite levels, while controlling for measurement method (Cr-ratio versus absolute concentrations). Decreased NAA concentrations that were specific to children were found for whole-brain grey and white matter. In addition, a significant decrease in NAA was evident across age categories in the parietal cortex, the cerebellum, and the anterior cingulate cortex. Higher levels of Cr were observed for ASD adults than children in global grey matter, with specific increases for adults in the temporal lobe and decreased Cr in the occipital lobe in children. No differences were found for either NAA or Cr in the frontal lobes. These data provide some evidence that ASD is characterized by age-dependent fluctuations in metabolite levels across the whole brain and at the level of specific regions thought to underlie ASD-associated behavioural and affective deficits. Differences in Cr as a function of age and brain region suggests caution in the interpretation of Cr-based ratio measures of metabolites. Despite efforts to control for sources of heterogeneity, considerable variability in metabolite levels was observed in frontal and temporal regions, warranting further investigation.

Although this metabolite is referred to in the literature as creatine (a convention adopted in this review), studies typically assay mixtures of the metabolites creatine and phosphocreatine. Likewise, the mixture of choline-containing compounds that are commonly measured is referred throughout the text as choline.

Allen G (2005) The cerebellum in autism. Clin Neuropsychiatry 6:321–337

Allen G, Courchesne E (2003) Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry 160(2):262–273PubMedCrossRef

American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn, text rev. Washington, DC: American Psychiatric Publishing, Inc

Autism and Developmental Disabilities Monitoring Network (ADDM) (2009) Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, United States, 2006. Morbidity and Mortality Weekly Report 58:SS-10

Baron-Cohen S, Wheelwright S (2004) The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord 34:163–175PubMedCrossRef

Bailey A et al (1998) Aclinicopathological study of autism. Brain 121:889–905PubMedCrossRef

Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ (2004) Autism and abnormal development of brain connectivity. J Neurosci 24(42):9228–9231PubMedCrossRef

Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E, Hof PR, Fan J (2011) In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 1380:198–205PubMedCrossRef

Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15(289):298

Brugha TS, McManus S, Bankart J, Scott F, Purdon S, Smith J, Bebbington P, Jenkins R, Meltzer H (2011) Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry 68(459):465

Buxbaum LJ, Kyle KM, Menon R (2005) On beyond mirror neurons: internal representations subserving imitation and recognition of skilled object-related actions in humans. Brain Res Cogn Brain Res 25:226–239PubMedCrossRef

Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ (1999) Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry 23(4):635–641PubMedCrossRef

Clark JB (1998) N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20(271):276

Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG (1994) Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 44:1411–1417PubMedCrossRef

Courchesne E (2004) Brain development in autism: early overgrowth followed by premature arrest of growth. Ment Retard Dev Disabil Res Rev 10:106–111PubMedCrossRef

Courchesne E, Pierce K (2005) Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long distance disconnection. Curr Opin Neurobiol 15(2):225–230PubMedCrossRef

Critchley HD, Daly EM, Bullmore ET, Williams SC, Van Amelsvoort T, Robertson DM, Rowe A, Phillips M, McAlonan G, Howlin P, Murphy DG (2000) The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123(11):2203–2212PubMedCrossRef

Czéh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, Bartolomucci A, Fuchs E (2001) Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 98:12796–12801PubMedCrossRef

Dhar SU, Scaglia F, Li FY, Smith L, Barshop BA, Eng CM, Haas RH, Hunter JV, Lotze T, Maranda B, Willis M, Abdenur JE, Chen E, O’Brien W, Wong LJ (2009) Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab 96:38–43PubMedCrossRef

Deeks J, Higgins J, Altman D (2008) Cochrane Reviewers’ Handbook 5.0.0 [updated February 2008]. In: Higgins J, Green S (eds) The Cochrane Library. Chichester, John Wiley & Sons Ltd

Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C (2001) N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 77:408–415PubMedCrossRef

Devinsky O, Morrell MJ, Vogt BA (1995) Contributions of anterior cingulate cortex to behaviour. Brain 118(1):279–306PubMedCrossRef

DeVito TJ, Drost DJ, Neufeld RW, Rajakumar N, Pavlosky W, Williamson P, Nicolson R (2007) Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 61(4):465–473PubMedCrossRef

Di Martino A, Ross K, Uddin LQ, Sklar AB, Castellanos FX, Milham MP (2009) Functional brain correlates of social and nonsocial processes in autism spectrum disorders: an activation likelihood estimation meta-analysis. Biol Psychiatry 65:63–74PubMedCrossRef

Endo T, Shioiri T, Kitamura H, Kimura T, Endo S, Masuzawa N, Someya T (2007) Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biol Psychiatry 62(9):1030–1037PubMedCrossRef

Erecińska M, Silver IA (1990) Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35(4):245–296PubMedCrossRef

Fayed N, Modrego PJ (2005) Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 12(5):566–569PubMedCrossRef

Friedman SD, Shaw DW, Artru AA, Richards TL, Gardner J, Dawson G, Posse S, Dager SR (2003) Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 60:100–107PubMedCrossRef

Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR (2006) Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry 63(7):786–794PubMedCrossRef

Frith U, Frith C (2001) The biological basis of social interaction. Curr Direct Psycholog Sci 10:151–155CrossRef

Fujii E, Mori K, Miyazaki M, Hashimoto T, Harada M, Kagami S (2010) Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study. J Med Invest 57(1–2):35–44PubMedCrossRef

Gabis L, Huang W, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y, Roche P, Pomeroy J (2008) 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. J Child Neurol 23(7):766–774PubMedCrossRef

Ganz ML (2007) The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med 161(4):343–349PubMedCrossRef

Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello I, Barthélémy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7(8):801–802PubMedCrossRef

Hadjikhani N, Joseph RM, Snyder J, Chabris CF, Clark J, Steele S, McGrath L, Vangel M, Aharon I, Feczko E, Harris GJ, Tager-Flusberg H (2004) Activation of the fusiform gyrus when individuals with autism spectrum disorder view faces. Neuroimage 22:1141–1150PubMedCrossRef

Hadjikhani N, Joseph RM, Snyder J, Tager-Flusberg H (2006) Anatomical differences in the mirror neuron system and social cognition network in autism. Cereb Cortex 16(9):1276–1282PubMedCrossRef

Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H, Matsuda T (2011) Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. J Autism Dev Disord 41(4):447–454PubMedCrossRef

Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R, Keshavan MS, Stanley JA (2008) An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 163(2):97–105PubMedCrossRef

Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y (1995) Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord 25(1):1–18PubMedCrossRef

Hashimoto T, Tayama M, Miyazaki M, Yoneda Y, Yoshimoto T, Harada M, Miyoshi H, Tanouchi M, Kuroda Y (1997) Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. J Child Neurol 12(2):91–96

Hashimoto T, Kawano N, Fukuda K, Endo S, Mori K, Yoneda Y, Yamaue T, Harada M, Miyoshi K (1998) Proton magnetic resonance spectroscopy of the brain in three cases of Rett syndrome: comparison with autism and normal controls. Acta Neurol Scand 98(1):8–14PubMedCrossRef

Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, Bienstock CA, Hollander E (2000) Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry 157:1994–2001PubMedCrossRef

Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic, San Diego

Herbert MR, Ziegler DA, Makris N, Filipek PA, Kemper TL, Normandin JJ, Sanders HA, Kennedy DN, Caviness VS Jr (2004) Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 55(4):530–540PubMedCrossRef

Hisaoka S, Harada M, Nishitani H, Mori K (2001) Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology 43(6):496–498PubMedCrossRef

Just MA, Cherkassky VL, Keller TA, Kana RK, Minshew NJ (2007) Functional and anatomical cortical underconnectivity in autism: evidence from an fMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex 17(4):951–961PubMedCrossRef

Kemper TL, Bauman ML (1993) The contribution of neuropathologic studies to the understanding of autism. Neurol Clin 11:175–187PubMed

Kleinhans NM, Schweinsburg BC, Cohen DN, Müller RA, Courchesne E (2007) N-acetyl aspartate in autism spectrum disorders: regional effects and relationship to fMRI activation. Brain Res 1162:85–97PubMedCrossRef

Kleinhans NM, Richards T, Weaver KE, Liang O, Dawson G, Aylward E (2009) Brief report: biochemical correlates of clinical impairment in high functioning autism and Asperger’s disorder. J Autism Dev Disord 39(7):1079–1086PubMedCrossRef

Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22(17):2693–2710PubMedCrossRef

Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA (2005) Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 24:810–821PubMedCrossRef

Le Couteur A, Lord C, Rutter M (2003) Autism diagnostic interview-revised (ADI-R). Western Psychological Services, Los Angeles

Leslie KR, Johnson-Frey SH, Grafton ST (2004) Functional imaging of face and hand imitation: towards a motor theory of empathy. Neuroimage 21:601–607PubMedCrossRef

Levitt JG, O’Neill J, Blanton RE, Smalley S, Fadale D, McCracken JT, Guthrie D, Toga AW, Alger JR (2003) Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biol Psychiatry 54(12):1355–1366PubMedCrossRef

Li BS, Wang H, Gonen O (2003) Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21:923–928PubMedCrossRef

Löllgen H, Böckenhoff A, Knapp G (2009) Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med 30(3):213–224PubMedCrossRef

Lord C, Rutter M, DiLavore P, Risi S (1999) Autism Diagnostic Observation Schedule-WPS, WPSth edn. Western Psychological Services, Los Angeles

Lundbom N, Gaily E, Vuori K, Paetau R, Liukkonen E, Rajapakse JC, Valanne L, Häkkinen AM, Granström ML (2001) Proton spectroscopic imaging shows abnormalities in glial and neuronal cell pools in frontal lobe epilepsy. Epilepsia 42:1507–1514PubMedCrossRef

McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, Suckling J, Simmons A, Sigmundsson T, Greenwood K, Russell A, Schmitz N, Happe F, Howlin P, Murphy DG (2002) Brain anatomy and sensorimotor gating in Asperger’s syndrome. Brain 125(7):1594–1606PubMedCrossRef

Miller BL, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden DJ (1996) In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 58(22):1929–1935PubMedCrossRef

Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA (2007) N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog Neurobiol 81(2):89–131PubMedCrossRef

Muller RA, Kleinhans N, Kemmotsu N, Pierce K, Courchesne E (2003) Abnormal variability and distribution of functional maps in autism: an FMRI study of visuomotor learning. Am J Psychiatry 160(10):1847–1862PubMedCrossRef

Murphy DG, Critchley HD, Schmitz N, McAlonan G, Van Amelsvoort T, Robertson D, Daly E, Rowe A, Russell A, Simmons A, Murphy KC, Howlin P (2002) Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 59(10):885–891PubMedCrossRef

Murphy FC, Nimmo-Smith I, Lawrence AD (2003) Functional neuroanatomy of emotion: a meta-analysis. Cogn Affect Behav Neurosci 3:207–233PubMedCrossRef

Murphy DG, Beecham J, Craig M, Ecker C (2011) Autism in adults. New biological findings and their translational implications to the cost of clinical services. Brain Res 1380:22–33PubMedCrossRef

Nasrallah F, Feki M, Kaabachi N (2010) Creatine and creatine deficiency syndromes: biochemical and clinical aspects. Pediatr Neurol 42(3):163–171PubMedCrossRef

Nordahl CW, Dierker D, Mostafavi I, Schumann CM, Rivera SM, Amaral DG, Van Essen DC (2007) Cortical folding abnormalities in autism revealed by surface-based morphometry. J Neurosci 27(43):11725–11735PubMedCrossRef

O’Brien FM, Page L, O’Gorman RL, Bolton P, Sharma A, Baird G, Daly E, Hallahan B, Conroy RM, Foy C, Curran S, Robertson D, Murphy KC, Murphy DG (2010) Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. Psychiatry Res 184(2):77–85PubMedCrossRef

Ohnishi T, Matsuda H, Hashimoto T, Kunihiro T, Nishikawa M, Uema T, Sasaki M (2000) Abnormal regional cerebral blood flow in childhood autism. Brain 123(9):1838–1844PubMedCrossRef

Oner O, Devrimci-Ozguven H, Oktem F, Yagmurlu B, Baskak B, Munir KM (2007) Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls. AJNR Am J Neuroradiol 28(8):1494–1498PubMedCrossRef

Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H (1999) Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology 41(7):517–519PubMedCrossRef

Page LA, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q, Ambery F, McAlonan GM, Murphy KC, Murphy DG (2006) In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 163(12):2189–2192PubMedCrossRef

Palmen SJ, Pol HE, Kremner C, Schnack HG, Janssen J, Kahn RS, Van Engeland H (2004) Larger brains in medication naïve high-functioning subjects with pervasive developmental disorder. J Autism Dev Disord 34:603–613PubMedCrossRef

Piven J, Rabins P, Autism-in-Older Adults Working Group (2011) Autism spectrum disorders in older adults: toward defining a research agenda. J Am Geriatr Soc 59(11):2151–2155PubMedCrossRef

Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143:862–866PubMed

Rogers SJ, Hepburn SL, Stackhouse T, Wehner E (2003) Imitation performance in toddlers with autism and those with other developmental disorders. J Child Psychol Psychiatr Allied Discip 44:763–781CrossRef

Sager TN, Laursen H, Hansen AJ (1995) Changes in N-acetylaspartate content during focal and global brain ischemia of the rat.J. Cereb Blood Flow Metab 15:639–646CrossRef

Salmond CH, Vargha-Khadem F, Gadian DG, de Haan M, Baldeweg T (2007) Heterogeneity in the patterns of neural abnormality in autistic spectrum disorders: evidence from ERP and MRI. Cortex 43(6):686–699PubMedCrossRef

Sartorius A, Lugenbiel P, Mahlstedt MM, Ende G, Schloss P, Vollmayr B (2008) Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 172:215–219PubMedCrossRef

Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64:12–21PubMedCrossRef

Schirmer T, Auer DP (2000) On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 13:28–36PubMedCrossRef

Schultz RT (2005) Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci 23:125–141PubMedCrossRef

Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, Buonocore MH, Lammers CR, Reiss AL, Amaral DG (2004) The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24:6392–6401PubMedCrossRef

Simister RJ, Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS (2002) A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 43:1021–1031PubMedCrossRef

Stromberger C, Bodamer OA, Stöckler-Ipsiroglu S (2003) Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism. J Inherit Metab Dis 26:299–308PubMedCrossRef

Suzuki K, Nishimura K, Sugihara G, Nakamura K, Tsuchiya KJ, Matsumoto K, Takebayashi K, Isoda H, Sakahara H, Sugiyama T, Tsujii M, Takei N, Mori N (2010) Metabolite alterations in the hippocampus of high-functioning adult subjects with autism. Int J Neuropsychopharmacol 13(4):529–534PubMedCrossRef

Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, New York

Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48

Tallan HH, Moore S, Stein WH (1956) N-acetyl-l-aspartic acid in brain. J Biol Chem 219:257–264PubMed

Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13(3):981–989PubMed

Wallace GL, Dankner N, Kenworthy L, Giedd JN, Martin A (2010) Age-related temporal and parietal cortical thinning in autism spectrum disorders. Brain 133(12):3745–3754PubMedCrossRef

Wechsler D (1991) The Wechsler intelligence scale for children—third edition. The Psychological Corporation, San Antonio

Wechsler D (1997) Wechsler adult intelligence scale—3rd Edition (WAIS-3®) San Antonio. Harcourt Assessment, TX

Titel: 1H-MRS in autism spectrum disorders: a systematic meta-analysis
verfasst von: Jonathan C. Ipser
Supriya Syal
Judy Bentley
Colleen M. Adnams
Bennie Steyn
Dan J. Stein
Publikationsdatum: 01.09.2012
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 3/2012
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-012-9293-y

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer’s disease

Maternal separation enhances object location memory and prevents exercise-induced MAPK/ERK signalling in adult Sprague–Dawley rats

The effects of vasopressin and oxytocin on methamphetamine–induced place preference behaviour in rats

Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate

Exposure to prenatal stress enhances the development of seizures in young rats